Pharmaceutical Companies

Basilea Pharmaceutica AG

Country: 🇨🇭Switzerland

Ownership: Public

Established: 2000-01-01

Employees: 147

Market Cap: $676.7M

Website: http://www.basilea.com

Basilea Pharmaceutica AG

🇨🇭Switzerland

Ownership: Public

Established: 2000-01-01

Employees: 147

Market Cap: $676.7M

Website: http://www.basilea.com

Y-mAbs Therapeutics

Country: 🇺🇸United States

Ownership: Public

Established: 2015-04-01

Employees: 100

Market Cap: $676.1M

Website: http://www.ymabs.com

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Y-mAbs Therapeutics

🇺🇸United States

Ownership: Public

Established: 2015-04-01

Employees: 100

Market Cap: $676.1M

Website: http://www.ymabs.com

Olema Pharmaceuticals

Country: 🇺🇸United States

Ownership: Public

Established: 2007-01-01

Employees: 74

Market Cap: $668.8M

Website: http://www.olema.com

Olema Pharmaceuticals

🇺🇸United States

Ownership: Public

Established: 2007-01-01

Employees: 74

Market Cap: $668.8M

Website: http://www.olema.com

SIGA Technologies

Country: 🇮🇳India

Ownership: -

Established: -

Employees: 45

Market Cap: $665.8M

Website: -

SIGA Technologies

🇮🇳India

Ownership: -

Established: -

Employees: 45

Market Cap: $665.8M

Website: -

Avid Bioservices

Country: 🇺🇸United States

Ownership: Public

Established: 1981-01-01

Employees: 371

Market Cap: $654.2M

Website: http://avidbio.com

Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981...

Avid Bioservices

🇺🇸United States

Ownership: Public

Established: 1981-01-01

Employees: 371

Market Cap: $654.2M

Website: http://avidbio.com

KYORIN PHARMACEUTICAL CO., LTD.

Country: 🇯🇵Japan

Ownership: Public

Established: 1958-10-31

Employees: 2K

Market Cap: $650.6M

Website: http://www.kyorin-pharm.co.jp

KYORIN PHARMACEUTICAL CO., LTD.

🇯🇵Japan

Ownership: Public

Established: 1958-10-31

Employees: 2K

Market Cap: $650.6M

Website: http://www.kyorin-pharm.co.jp

AARTI DRUGS LIMITED

Country: 🇮🇳India

Ownership: -

Established: -

Employees: -

Market Cap: $640.2M

Website: -

AARTI DRUGS LIMITED

🇮🇳India

Ownership: -

Established: -

Employees: -

Market Cap: $640.2M

Website: -

Annexon

Country: 🇺🇸United States

Ownership: Public

Established: 2011-01-01

Employees: 71

Market Cap: $639.2M

Website: http://www.annexonbio.com

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3,...